Chimerix Inc (CMRX): Chimerix's CEO Presents at 32nd Annual JPMorgan ... Seeking Alpha We have publicly discussed the fact that we believe the next trial we will undertake, which will be used for traditional approval would be in solid organ transplantation, particularly focused on kidney transplantation, obviously to open the market into ... |
